| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.6 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.6 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | vorinostat:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.027 | 0.6 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |